Beltapharm SPA DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

BMS' Anemia Drug Reblozyl Flunks Phase III Myelofibrosis Trial

19 Jul 2025

// BIOSPACE

FDA Rejects Roche's Earlier DLBCL Bid Over Lackluster US Data

19 Jul 2025

// PRESS RELEASE

Kenvue collaborates with API to launch India’s first cough clinic

19 Jul 2025

// INDPHARMAPOST

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

APGA Annual Conference

Not Confirmed

Book a meeting

envelop Contact Supplier

INSPECTIONS & REGISTRATIONS

3 FDA, 1 EDQM, 1 GDUFA

inspections
3 FDA
1 EDQM
1 GDUFA

About

BELTAPHARM S.p.A. was started in 1982 by a team of entrepreneurs with experience in the pharmaceutical field. Its scope is the production by contract manufacturing of pharmaceuticals for human. These are produced in the commonest pharmaceutical forms, mainly as generics (ex galenics), for export outside Europe (Africa, Asia and Latin America). Beltapharm S.p.A is approved as third-party manufacturer by several Italian and European companies for the production of pharmaceuticals in liquid and semi-solid forms, with a particular emphasis on steroid-based products like: cream,ointments and gels, both for human and veterinary use.